Ticker Symbol: VYNT
Vyant Bio Inc
$2.17 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001349929
Company Profile
Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.
Sector: Health Care and Social Assistance
Industry: Medical Laboratories
Standard Industrial Classification Code (SIC code): 8071
Address: 201 State Rt 17 Fl 2
Website: www.vyantbio.com
CEO: John Roberts
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.17
Change:
-
(
0.00%)
Days Range: $0.17 - $0.17
Beta: -
52wk. High: $0.35
52wk. Low: $0.14
Ytd. Change -31.00%
50 Day Moving Average: $0.16
200 Day Moving Average: $0.19
Shares Outstanding: 6328752
Valuation
Market Cap: 109.2M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A